Image default
Water News

WHO says it will have advice on Remdesivir in 3-4 weeks

GENEVA: The World Health Organization is preparing its guidelines on the use of the drugremdesivirto treat COVID-19, and should be able to release it in three to four weeks, theWHO‘s top official for clinical care responses said.

“We would anticipate that the guidelines will be available within three to four weeks,” Janet Diaz told a news conference. A WHO panel “will convene next week to look at the totality of the evidence” of the effectiveness of the drug, made by Gilead Sciences.

(Catch all theBusiness News,Breaking NewsEvents andLatest NewsUpdates onThe Economic Times.)

Download The Economic Times News App to get Daily Market Updates & Live Business News.


Related posts

AIIMS chief calls for PPP for large-scale rollout of COVID-19 vaccination programme


Hunting in savanna-like landscapes may have poured jet fuel on brain evolution: Rife with obstacles and occlusions, terrestrial environments potentially helped give rise to planning circuits in the brain


USFDA issues warning to Shilpa Medicare for CGMP violations at Telangana plant


Leave a Comment